Pfizer’s EAGLES trial finds Chantix safe in smokers with psychiatric disorders

Pfizer has reported positive results from EAGLES, a multi-centre, parallel-group, post-authorisation safety study / post-marketing requirement (PASS / PMR), which was conducted in 16 countries in collaboration with GlaxoSmithKline.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news